CME Grant Disclosure and Transparency: Company Reports 2010 and 1st Half 2011

We have compiled a chart of companies that disclose their educational grant payments for  2010 and 2011.  There are still a few companies that do not disclose their educational grant payments however, once the Physician Payment Sunshine Act regulations are released sometime before the end of this year by the Centers for Medicare and Medicaid Services (CMS), it is likely that more companies will begin to post such payments in anticipation of the rules to assist with implementation and compliance.

Company 2011 2010 2009 2008
 
Abbott   Q1 Q1
  Q2 Q2
  Q3 Q3 Q3
  Q4 Q4
 
Amgen Q1 Q1 Q1 Q1
Q2 Q2 Q2 Q2
  Q3 Q3 Q3
  Q4 Q4 Q4
 
Amilyn   Q1 Q1
  Q2 Q2
  Q3 Q3
  Q4
 
Amilyn Lilly Grant Office   Q1 Q1
  Q2 Q2
  Q3 Q3
  Q4
Astellas Pharma US, Inc. Q1 Q1 Q4
Q2 Q2
  Q3
  Q4
 
Astra Zeneca   1st ½ of 2010 1st ½ of 2009 1st ½ of 2008
  2nd ½ of 2010 2nd ½ of 2009 2nd ½ of 2008
 
Bristol-Myers Squibb Q1 Q1
Q2 Q2
  Q3
  Q4
 
Glaxo Smith Kline 1st & 2nd Quarter 2011 Full Year Full Year Full Year 2008
 
Genentech Q1 Q1
  Q2
  Q3
  Q4
 
Johnson and Johnson Companies  
 
Biosense Webster Q1 2011 – Q2 2010
Centocor Ortho Biotech Q1 & Q2 2011
Cordis Q1 2011 – Q2 2010
Depuy  
Depuy Mitek, Inc. Q1 2011 – Q2 2010
Depuy Orthopaedics, Inc. Q1 2011 – Q1 2010
Depuy Spine, Inc. Q1 2011 – Q2 2010
Codman and Shurtleff, Inc. Q1 2011 – Q2 2010
Ethicon Q1 2011 – Q2 2010
Ethicon Endo Surgery, Inc. Q1 2011 – Q1 2010
Janssen Pharmaceuticals, Inc. Q1 & Q2 2011
Lifescan Q1 2011 – Q2 2010
Janessen Biotech, Inc. Q1 & Q2 2011
Janssen Therapeutics Q1 & Q2 2011
Therakos Q1 2011 – Q2 2010
Eli Lilly Q1 Full Year Full Year
 
Merck   Q1 Q1 Q3
  Q2 Q2 Q4
  Q3 Q3
  Q4 Q4
 
Pfizer Q1 & Q2 – 2011 2010 2009 2008
 
Sanofi Aventis Q1 Q1 Q1
  Q2 Q2
  Q3 Q3
  Q4 Q4
 
Shire Q1 Q1 Q1
Q2 Q2 Q2
  Q3 Q3
  Q4 Q4
NEW
Comments (0)
Add Comment